Search Finnegan

Articles

Counting Patents, Not Progress: Another Misdiagnosis by I-MAK Counting Patents, Not Progress: Another Misdiagnosis by I-MAK

Articles

Certification Mark Pitfalls: Managing Problems of Genericness, Descriptiveness, and Consumer Perception Certification Mark Pitfalls: Managing Problems of Genericness, Descriptiveness, and Consumer Perception

Webinar

Strategies for Effectively Enhancing IP Value of Critical Assets After Teva v. Amneal and Other Recent Decisions Strategies for Effectively Enhancing IP Value of Critical Assets After Teva v. Amneal and Other Recent Decisions

Federal Circuit IP Blog

Don’t Sleep on This: Federal Circuit Reverses Permanent Injunction Barring Clinical Trials and New Indications for NDA Don’t Sleep on This: Federal Circuit Reverses Permanent Injunction Barring Clinical Trials and New Indications for NDA

Articles

Strategies for Effectively Enhancing IP Value of Critical Assets after Teva v. Amneal and Other Recent Decisions Strategies for Effectively Enhancing IP Value of Critical Assets after Teva v. Amneal and Other Recent Decisions

Webinar

Patenting Pharmaceutical Drug Formulations: Withstanding Litigation and PTAB Challenges Patenting Pharmaceutical Drug Formulations: Withstanding Litigation and PTAB Challenges

Conference

2024 AIPPI World Congress 2024 AIPPI World Congress

Conference

4th Annual Passport to Proficiency on the Essentials of Hatch-Waxman and BPCIA 4th Annual Passport to Proficiency on the Essentials of Hatch-Waxman and BPCIA